Dolphin Vagal Nerve Stimulation for COVID-19

Health Canada Approved: Dolphin Vagal Nerve Stimulation for COVID-19

COVID 19 IS AN INFECTIOUS DISEASE

that may lead to Acute Respiratory Distress Syndrome (ARDS), characterized by widespread inflammation in the lungs, inflammatory cytokine storms, and respiratory dysfunction.

COVID-19 mortality is due to our bodies inability to counter the inflammatory “Sympathetic Storm” which spreads “like wildfire” through the bloodstream to cause multiorgan failure. (Kaniusas 2020)

Vagus Nerve to the Rescue


The Vagus Nerve is the 10th cranial nerve, representing 80% of your parasympathetic nervous system healing response and is the counterbalance to your sympathetic fight or flight system. Vagus Nerve controls a vast array of crucial bodily systems, including: immunity, digestion, anti-inflammatory and respiratory functioning.The Vagus Nerve is the 10th cranial nerve, representing 80% of your parasympathetic nervous system healing response and is the counterbalance to your sympathetic fight or flight system. Vagus Nerve controls a vast array of crucial bodily systems, including: immunity, digestion, anti-inflammatory and respiratory functioning.

Dolphin Vagal Nerve Stimulator (VNS) is NOW authorized for emergency use in the acute treatment of adult patients with known or suspected COVID-19. Dolphin VNS is intended for patients experiencing asthma-related dyspnea or reduced airflow (called Acute Respiratory Distress Syndrome – ARDS) relating to COVID-19.

Dolphin Vagal Nerve Stimulator (VNS) is ideal for patients where approved drug therapies are not tolerated or provide insufficient respiratory symptomatic relief, and applying non-invasive Dolphin VNS to the auricular branch of the vagus nerve (ABVN) may help COVID related respiratory distress.

Vagal Nerve Stim counters Covid-19 ARDS

Introducing Dolphin Vagal Nerve Stimulation
Health Canada Approved for COVID-19

Health Canada Approval

Dolphin Vagal Nerve Stimulator is NOW authorized for emergency use in the acute treatment of COVID-19 ARDS

Active Vagal Tone Treating

Less than 10 minutes treating super-charges your vagal tone (+56%)

Passive Vagal Tone Treating

Less than 15 minutes PASSIVE treating super-charges your vagal tone (+54%)

DOLPHIN VNS COVID -19 APPLICATIONS

Acute: COVID-19 Respiratory

Dolphin Vagal Nerve Stimulator is NOW authorized for emergency use in the acute treatment of COVID-19 ARDS

Prevention: Immunity Enhance

Front Line workers need extra immunity protection that enhancing Vagal Tone offers.

Long-Haul COVID Recovery

COVID-19 Long Haulers suffer from stress-related disorders long after acute symptoms go away. Activating Vagal tone can reverse many symptoms

Dolphin VNS is Superior Vagal Stim

Dolphin VNS is a hybrid form of Vagal Nerve Stimulation that applies a unique low-frequency (Hz) DC microcurrent stimulation to the ear.

Traditional VNS systems treat ONLY the “root” or proximal end of the vagas nerve, provding limited benefits.

Using Vagal Up accessories, Dolphin’s delivers unique VNS stimulus throughout the entire vagas nerve track guaranteeing a much deeper and stronger vagal tone enhancement than traditional VNS approaches.